Clinical Trial Update: Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing olanzapine to an active comparator in schizophrenia has completed, evaluating efficacy and safety outcomes. The trial was sponsored by E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED